Commentary to Eligibility of Common Femoral Artery Atherosclerotic Disease For Endovascular Treatment: The CONFESS Study. Goueffic Y, Nasr B. Eur J Vasc Endovasc Surg 2022;64:692.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goueffic Y, Nasr B. Commentary to Eligibility of Common Femoral Artery Atherosclerotic Disease For Endovascular Treatment: The CONFESS Study. Eur J Vasc Endovasc Surg 2022;64:692.
PMID: 36170942